Related Experiment Video
Updated: Aug 14, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Preventative and therapeutic vaccines for fungal infections: from concept to implementation
1University of Cincinnati College of Medicine, Division of Infectious Diseases, Cincinnati, Ohio 45267-0560, USA. george.deepe@uc.edu
Abstract:
Many challenges confront the development of fungal vaccines for humans including differences in host susceptibility, varied pathogenic mechanisms employed by the different species of fungi and mechanisms of host resistance. Hence, no single antigen can be expected to serve as a pan fungal vaccine. Instead, it is likely that progress for fungal vaccines will have to be made at the level of each individual organism. In recent years, tremendous strides have been made in understanding the immunopathogenesis of medically important fungal infections and identifying putative vaccine candidates. Such discoveries will facilitate the introduction of fungal vaccines into the therapeutic armamentarium of clinicians. The fungi under discussion in this review include Candida spp., Aspergillus spp., Cryptococcus neoformans, Coccidioides spp., Histoplasma capsulatum, Blastomyces dermatitidis, Paracoccidioides brasiliensis and Pneumocystis jirovecii.
Insights
Developing effective fungal vaccines for humans faces challenges due to diverse fungal pathogens and host responses. Research is advancing understanding of fungal infections, paving the way for organism-specific vaccine candidates.
Area of Science:
- Medical Mycology
- Vaccinology
- Immunology
Background:
- Human fungal infections present significant health challenges due to complex host-pathogen interactions.
- Developing broad-spectrum fungal vaccines is hindered by the diversity of fungal species and their pathogenic mechanisms.
- Existing therapeutic options for invasive fungal diseases are limited, highlighting the need for novel preventative strategies.
Purpose of the Study:
- To review the current challenges and recent advancements in the development of fungal vaccines.
- To identify potential vaccine candidates for medically important fungal infections.
- To discuss the immunopathogenesis of fungal diseases and host resistance mechanisms.
Main Methods:
- Review of recent scientific literature on fungal vaccines and immunopathogenesis.
- Analysis of challenges in developing universal fungal vaccines.
- Identification of specific fungal pathogens and their associated vaccine research.
Main Results:
- No single antigen is suitable for a pan-fungal vaccine; organism-specific approaches are necessary.
- Significant progress has been made in understanding the immune response to fungal infections.
- Numerous potential vaccine candidates have been identified for various fungal species.
Conclusions:
- Advancements in understanding fungal immunopathogenesis are crucial for vaccine development.
- Future fungal vaccines will likely be tailored to individual fungal organisms.
- These discoveries hold promise for improving the clinical management of fungal infections.
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Vaccines
Cryptococcal Meningitis
Antifungal Agents

